Traditional facilities lack the adaptability to accommodate new therapies and processes. Typically, they have been purposely designed to manufacture a single blockbuster biopharmaceutical product but are often seen as slow to design and slow to build.
For years this has been effective for many large-scale processes, but as industry evolves these systems are no longer able to meet all the needs of new modalities and small-scale personalized treatments which seek to achieve ever-faster development timelines and ways to reduce capital risk. So, it is easy to see how flexibility, adaptability and enhanced process control through automation will be key attributes to achieving successful and cost-effective bioprocessing.
Learn how a modular design approach helps overcome bioprocessing challenges to deliver more value.